Stock Rich List
#12086 on the rich list of 14,452 insiders

Julie L. Gerberding

EVP, Chief Patient Officer at Merck & Co.. Based in Kenilworth, New Jersey.

$6.5M
in disclosed stock, −$242K (−3.61%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
12086th of 14,452
Companies held
1
Largest holding
MRK, 100.0% of total
Latest SEC filing
Feb 24, 2022

What the $6.5M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Merck & Co. MRK
Common Stock
Directly48,712$132.81$6.5M100.0%Form 4, Feb 24, 2022

Share counts are the amounts Julie L. Gerberding reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
12083George Barr
Director, First Busey. Champaign, IL
$6.5M−$112K (−1.71%)
12084Theodore B. Lundberg
Director, AdaptHealth. Conshohocken, PA
$6.5M−$107K (−1.63%)
12085Richard Blackshaw
EVP, Brand President, Crocs. Broomfield, CO
$6.5M−$224K (−3.35%)
12086Julie L. Gerberding
EVP, Chief Patient Officer, Merck & Co.. Kenilworth, NJ
$6.5M−$242K (−3.61%)
12087Jay Stout
Chief Technology Officer, Immunovant. Durham, NC
$6.5M−$129K (−1.96%)
12088J. Kevin Buchi
Director, Amneal Pharmaceuticals. Bridgewater, NJ
$6.5M−$145K (−2.20%)
12089Cormac Stuart
Chief Accounting Officer, AerCap Holdings
$6.5M−$121K (−1.84%)

Other Merck & Co. insiders

All MRK insiders

Questions

How much stock does Julie L. Gerberding own?

Julie L. Gerberding holds $6,469,459 in listed stock based on SEC filings and current prices, mostly Merck & Co. (MRK). That ranks 12086th on the Stock Rich List.

Is this Julie L. Gerberding's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.